Abbott Laboratories (ABT)

0.98 1.20
NYSE : Health Technology
Prev Close 84.78
Open 85.79
Day Low/High 85.33 / 86.08
52 Wk Low/High 64.03 / 88.76
Volume 1.29M
Avg Volume 4.98M
Exchange NYSE
Shares Outstanding 1.77B
Market Cap 148.36B
EPS 1.30
P/E Ratio 51.81
Div & Yield 1.28 (1.48%)

Abbott upgraded at Credit Suisse

Deutsche Healthcare Conf.

Abbott price target cut at Jefferies

Edward Jones: EMC, Devon Offer Growth Opportunities

Edward Jones: EMC, Devon Offer Growth Opportunities

The demand for storage is greater than ever due to increased regulatory requirements and internet usage, which is why EMC remains a stock worth owning.

Abbott price target cut at Jefferies

Calling the Right Plays in 2014

Great investors and great quarterbacks have a lot in common.

Healthcare Holding Strong

Healthcare Holding Strong

It's clear that bulls in this sector aren't weak hands.

Abbott Labs Breaks Out

Abbott Labs Breaks Out

Bullish action has set the stock up well for more upside.

The Day Ahead: Full Speed Ahead

U.S. futures are positive to start first full week of 2014 trading.

Abbott upgraded at Morgan Stanley

Cramer: Too Much Negativity on Earnings

Update: Let's look at the big hits, not just the misses.

Earnings Look Good Through This Prism

This season isn't the drag it's made out to be.

The Day Ahead: Deal Hope Still There

UPDATE: Futures higher as Senate negotiations restart.

Early-Morning Market Look

Let's take a peek at overnight and early-morning price action in the major asset classes. Exit light Enter night Take my hand We're off to never never land. -- Metallica, "Enter Sandman" Let's take a peek at overnight and early-morning price action ...

Wells Healthcare Conf.

Rules of the Game: Identifying Growth Stocks

The objective of investing is to offset future liabilities and manage risk.

ABT Investor Mtg.

Cramer Talks Abbott & Glaxo

Cramer Talks Abbott & Glaxo

TheStreet's Jim Cramer says Abbott Labs will benefit from growth in emerging markets and Glaxo will benefit from a "huge pipeline of approvals." The Action Alerts Plus portfolio recently bought Glaxo shares and added to their position in Abbott Labs.

Health Care Stocks Still Promising

Plenty of leadership remains in the health care sector and there's reason to see further potential.

Seven to Watch

Trading at 7x earnings, these stocks are all poised to outperform the market this year.

Barclays Healthcare Conf.

It's a Good Time to Buy All-Weather Laggards

Don't chase recent winners, search for stocks that have good 2013 prospects.

Abbott target raised at Jefferies

Market on Close Imbalances

How much to sell? My mavens on the floor see $1.6 billion to sell market on close, so my observation earlier in the afternoon might have had some merit. In terms of sectors, the largest to buy include   health care ($ 85 ,million) and financials ($3...

Separating 'Facts' From 'Guidance'

Being behind the market or beating estimates isn't enough; guidance has to be good.

Chairman's Club Call Roundup

Markets would soar to all-time highs if our country's budget issues finally get resolved.